A Clinical Study of MK-4482 in Chinese Healthy Male Participants (MK-4482-009)
Clinical trial NCT06816030 · COMPLETED
Trial details
- NCT number
- NCT06816030
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-28
- Primary completion
- 2023-08-05
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.